Doctor Gema Minana Escriva
Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)
Serum neprilysin and recurrent hospitalizations after acute heart failure
Event: HEART FAILURE 2016
Topic: Prognosis (using biomarkers)
Session: Biomarkers
ESC 365 is supported by
